Search results for: 'cmo ad pics clinical'

The Sensor Technology Opportunity Engine provides profiles of innovations related to AI-driven multimodal sensor fusion platforms enabling autonomous perimeter security and threat detection; AI-enabled portable hyperspectral imaging platforms for real-time field inspection and material analysis; ultra-low-noise scientific CMOS sensors for high-prec...

The evolution in autonomy and increase in the adoption of driver assistance systems have generated a need to sense and perceive the surrounding environment of a vehicle entirely and accurately. The fusion of forward-looking sensor data has given OEMs and Tier-I suppliers opportunities to offer multiple ADAS applications at low costs, while providin...

Major automotive OEMs globally are now incorporating active safety and automated vehicle technologies in their future vehicle line-ups to enhance safety and driver comfort. To gauge the suitability of each technology, continuous testing and validation is a must. Based on supportive legislation, several regions across the globe have been identified ...

Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

In the last decade, nanomedicine and nanotechnology have helped unlock revolutionary therapeutic potential that has positively impacted healthcare. Among the different nanotechnology-based innovations, lipid-based nanoparticles such as liposomes and lipid nanoparticles (LNPs) show great promise across multiple therapies. Although the Food and Drug ...

This research service analyzes the market for clinical laboratory analyzers within the United States. The United States market was divided into the clinical chemistry, immunoassay, integrated, hematology, hemostasis, and blood gas analyzer market segments. Each segment of this service covers market drivers, market restraints, competitive structur...

The clinical laboratory instrumentation (CLI) market in Taiwan is a mature market that is approaching saturation. Taiwan has one of the best healthcare systems in Asia Pacific after Japan and offers both modern and comprehensive medical services to its population. The CLI market in Taiwan was valued at approximately $67.0 million in 2005 and is exp...

This study covers three countries in East Africa: Kenya, Uganda, Tanzania and their clinical diagnostics industry. Market, examining drivers and restraints for growth, pricing, distribution, technology, legislation, demand and geographical trends. Following from these, market growth for regional and market segments are forecasted. In addition, an i...